Meeting commentary-Formulating better medicines for children

International Journal of Pharmaceutics

Volumn 379, Issue 1-2, 2009, Pages 143-145

  Hempenstall, John ^a   Tuleu, Catherine ^b  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLORING AGENT; DRUG; DRUG PRESERVATIVE; EXCIPIENT; SOLUBILIZER; SOLVENT;

ACCESS TO INFORMATION; CHILD; CHILD HEALTH CARE; CLINICAL PRACTICE; CONFERENCE PAPER; DRUG ADMINISTRATION ROUTE; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG PACKAGING; DRUG RESEARCH; DRUG SAFETY; DRUG SYNTHESIS; DRUG TOLERABILITY; EVIDENCE BASED MEDICINE; HEALTH CARE ACCESS; HEALTH CARE NEED; HUMAN; INTERNET; MEDICAL LITERATURE; PALATABILITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; REFERENCE DATABASE; RISK ASSESSMENT; TABLET FORMULATION; TASTE PREFERENCE;

AGE FACTORS; CHILD; DRUG COMPOUNDING; DRUG INDUSTRY; EXCIPIENTS; HUMANS; PHARMACEUTICAL PREPARATIONS; TASTE;

EID: 68649089699     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.06.033     Document Type: Conference Paper

References (10)

1. Ayenew Z., Puri V., Kumar L., and Bansal A.K. Trends in pharmaceutical taste masking technologies: a patent review. Recent Pat. Drug Deliv. Formul. 3 (2009) 26-39
2. Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA), 2005. Reflection paper: formulations of choice for the paediatric population. EMEA/CHMP/PEG/194810/2005 [online]. Available from URL: http://www.emea.europa.eu/pdfs/human/paediatrics/19481005en.pdf. Last accessed on June 04, 2009.
3. Cram A., Breitkreutz J., Desset-Brèthes S., Nunn T., and Tuleu C. Challenges of developing palatable oral paediatric formulations. Int. J. Pharm. 365 (2009) 1-3
4. Davies E.H., and Tuleu C. Medicines for children: a matter of taste. J. Pediatr. 153 (2008) 599-604
5. Douroumis D. Practical approaches of taste masking technologies in oral solid forms. Exp. Opin. Drug Deliv. 4 (2007) 417-426
6. Formulating Better Medicines for Children, First EuPFI conference, 2nd to 3rd March 2009, London, UK.
7. Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004.
8. USA Public Law 107-109, Best Pharmaceuticals for Children Act, January 2002.
9. Whittaker A., Mulla H., Turner M.A., Currie A.E., Field D.J., and Pandya H.C. Toxic Additives in Medications for Preterm Infants. Arch. Dis. Child Fetal Neonatal Ed. 94 (2009) F236-F240
10. WHO Report of the Informal Expert Meeting on Dosage Forms of Medicines for Children. WHO Headquarters, Geneva, Switzerland, Dec. 2008. Available at URL http://www.who.int/selection_medicines/committees/expert/17/application/paediatric/Dosage_form_reportDEC2008.pdf last accessed on June 04, 2009.